|
The BAERVELDT® glaucoma implant is a glaucoma shunting device. BAERVELDT® glaucoma implants are available in three models, all of which feature a larger surface area plate than competing single-quadrant devices.1
BAERVELDT® glaucoma implants are a significant design accomplishment, combining the largest surface area in a streamlined device that can be implanted in a single quadrant. The potential clinical benefits of a large, single-quadrant implant are substantial:
 |
Model BG 103-250
Surface Area: 250 mm2
- Long-term intraocular pressure (IOP) control3,4
- Easier implantation3
- Reduced surgical time4
- Less trauma2,4
- Faster healing4
BAERVELDT® glaucoma implants feature a low implant profile, 0.84 mm, for better globe fit.1,6 The single-quadrant insertion is technically simpler and allows implantation with less trauma than multiple-quadrant surgery.2,3,4 The patented fenestrations of the BAERVELDT® glaucoma implant were designed to minimize bleb height and volume and help reduce ocular motility disturbances.1,3,5
The BAERVELDT® glaucoma implant is indicated for use in patients with medically uncontrollable glaucoma and poor surgical prognosis, such as, but not limited to: neovascular glaucoma; aphakic/pseudophakic glaucomas; failed conventional surgery, congenital glaucoma; and secondary glaucoma due to uveitis, epithelial downgrowth, etc.
Contraindications include bacterial conjunctivitis, bacterial corneal ulcers, endophthalmitis, orbital cellulitis, bacteremia or septicemia, active scleritis and/or no light perception.
Reported complications during and after surgery include, but are not limited to: choroidal hemorrhage, hyphema, serous choroidal effusion, hypotony, flat anterior chamber, phthisis bulbi, retinal detachment, endophthalmitis, tube erosion, tube touch to cornea, tube block by iris or vitreous, bullous keratopathy, uveitis, and diplopia.
Caution: Federal Law restricts this device to sale by or on the order of a physician.
|
